Longo-Muñoz, F.
Argiles, G.
Tabernero, J.
Cervantes, A.
Gravalos, C.
Pericay, C.
Gil-Calle, S.
Mizuguchi, H.
Carrato-Mena, A.
Limón, M. L.
Garcia-Carbonero, R.
Funding for this research was provided by:
Taiho Oncology Inc.
Article History
Received: 2 March 2016
Accepted: 20 June 2016
First Online: 21 July 2016
Compliance with ethical standards
:
: Author A reports employment at Taiho Oncology Inc. Author B reports providing scientific advice to Bayer. Author C reports consulting/advisory fees from Amgen, Boehringer Ingelheim, Celgene, Chugai, Imclone Systems Inc., Eli Lilly and Company, Merck & Co., Merck Serono, Millennium, Novartis, F. Hoffmann-La Roche Ltd., Sanofi, Symphogen, and Taiho Oncology Inc. All other authors declare that they have no conflicts of interest.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.